IL-23 inhibition is known to skew the IL-12/T-helper 1 (Th1) axis, resulting in increased interferon-γ (IFN-γ) production, a cytokine implicated in the early sensitization phase of allergic contact dermatitis (ACD). This evidence concerns the gene IFNG and allergic contact dermatitis.